Trending
- Biotech investment is the new front in the U.S.-China trade fight
- Goldman Sachs sends CoreWeave shareholders a surprising signal
- Carnival Cruise Line makes its drink package a guessing game
- Moderna stock’s 17% slump was a ‘sell the news’ event, analyst says
- Amazon’s 2-pack of rechargeable flashlights with 5 lighting modes is only $18
- eBay reveals another layoff round even as business improves
- Why Your Competitive Advantage Should Come Before Your Growth Plan
- Your Cash Flow Problem Isn’t the Problem. Here’s How to Diagnose What Is.
